State Street’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,162
Closed -$73.7K 4613
2023
Q2
$73.7K Hold
16,162
﹤0.01% 4305
2023
Q1
$86K Hold
16,162
﹤0.01% 4365
2022
Q4
$79.8K Hold
16,162
﹤0.01% 4436
2022
Q3
$104K Hold
16,162
﹤0.01% 4453
2022
Q2
$102K Hold
16,162
﹤0.01% 4531
2022
Q1
$112K Buy
16,162
+300
+2% +$2.12K ﹤0.01% 4612
2021
Q4
$110K Hold
15,862
﹤0.01% 4560
2021
Q3
$135K Hold
15,862
﹤0.01% 4476
2021
Q2
$110K Buy
+15,862
New +$111K ﹤0.01% 4341

Other funds holding PMD

State Street's PMD Position: Q3 2023 in Review

State Street sold out of Psychemedics Corporation (PMD) in Q3 2023, closing a stake of 16,162 shares — an estimated $73.7K sold.

State Street first reported a position in PMD in Q2 2021 and held it in 9 quarters. The position peaked at $135K in Q3 2021. 25 funds tracked by Wall St. Rank hold PMD as of Q3 2023.

  • State Street reported no remaining Psychemedics Corporation position as of Q3 2023 after selling out during the quarter.
  • State Street sold 16,162 Psychemedics Corporation shares in Q3 2023, an estimated $73.7K.
  • State Street first reported a position in Psychemedics Corporation in Q2 2021 and held it in 9 quarters.
  • State Street's Psychemedics Corporation position peaked at $135K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.